DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Filed By Glancy Binkow & Goldberg LLP

Blackstone-backed Catalent sets terms for $871 million IPO

UPDATE 1-Catalent expects IPO to be priced between $19-$22/shr

Tasmania, Big Supplier to Drug Companies, Faces Changes

Taking Cancer Drug With Food May Cut Costs

FDA Panel: 3 Asthma Drugs Can Stay

FDA Panel Seems Skeptical Over Key Avandia Data

Theravance/Glaxo Commence Global Late stage Study on COPD